Retinal amacrine cells express metabotropic glutamate receptors (mGluRs), but their physiological role is unknown. We investigated the effect of mGluR on [ 3 H]acetylcholine release ([ 3 H]ACh) from cultured chick amacrine-like neurons. Activation of group III mGluR with the agonist L(؉)-2-amino-4-p
Metabotropic glutamate receptor agonists reduce glutamate release from cultured astrocytes
✍ Scribed by Zu-Cheng Ye; Harald Sontheimer
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 160 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0894-1491
No coin nor oath required. For personal study only.
✦ Synopsis
Astrocytes are thought to control extracellular glutamate concentrations ([Glu] o ) in the brain, thereby protecting neurons from excitotoxic injury. We investigated the effects of metabotropic glutamate receptor (mGluR) agonists on glutamate transport and [Glu] o in primary hippocampal astrocytic cultures. Acute or chronic exposure of astrocytes to the mGluR agonist trans-1-aminocyclopentane-1,3dicarboxylic acid (trans-ACPD) or its active isomer 1S,3R-ACPD reduced [Glu] o in a timeand dose-dependent manner (44.5 Ϯ 3.6% reductions of [Glu] o in astrocytes from P0-P10 rats and 65.9 Ϯ 4.1 % from rats P20 by 100 µM 1S,3R-ACPD, EC 50 ϳ 5 µM). 1S,3R-ACPD effects developed slowly (median effective at ϳ60 min) and persisted for several hours after agonist removal. ACPD-pretreated astrocytes established lower steady-state [Glu] o levels. ACPD effects persisted in the presence of the glutamate uptake inhibitors D,L-threo--hydroxyaspartate (THA) and L-trans-pyrrolidine-2,4-dicarboxylate (PDC) but were impaired by disruption of the transmembrane Na ϩ , K ϩ , or H ϩ gradients. In addition, 1S,3R-ACPD had no effects on intracellular glutamate content and did not directly block glutamate transport. Furthermore, ACPD effects could be mimicked by glutamate per se and several other compounds presumed to be mGluR agonists, although (S)-3,5-dihydroxyphenylglycine (DHPG), (2S,2R,3R)-2-(2,3-dicarboxycyclopropyl)glycine (DCG-IV), and L-(ϩ)-2-amino-4-phosphonobutyric acid (L-AP4) were without effect. These data suggest that glutamate and certain mGluR agonists may regulate [Glu] o by modulating the transmembrane equilibrium of glutamate transport, especially by attenuating glutamate release.
📜 SIMILAR VOLUMES
## Abstract Several excitatory amino acid ligands were found potently to inhibit forskolin‐stimulated cAMP accumulation in rat cultured cerebellar astrocytes: L‐cysteine sulfinic acid (L‐CSA) = L‐aspartate > L‐glutamate ≥ the glutamate uptake inhibitor, L‐PDC. This property did not reflect activati
In non-synchronized, subconfluent secondary cultures of rat cortical astrocytes, the selective group-I metabotropic glutamate (mGlu) receptor agonist 3,5dihydroxyphenylglycine (DHPG) increased [methyl-3 H]-thymidine incorporation. This effect was mediated by the activation of the mGlu5 receptor, whi
## Abstract Nitric oxide (NO; 1 μM) or an NO donor (500 μM diethylenetriamine‐nitric oxide, DETA‐NONOate) caused rapid glutamate and ATP release from cultured rat cortical astrocytes. NO‐induced glutamate release was prevented by calcium chelators (EGTA or BAPTA‐AM) and an inhibitor of vesicular ex
Pharmacological activation of A 1 adenosine receptor with 2-chloro-N6cyclopentyladenosine (CCPA) or mGlu3 metabotropic glutamate receptors with (2S,2ЈR,3ЈR)-2-(2Ј,3Ј-dicarboxycyclopropyl)glycine (DCG-IV) or aminopyrrolidine-2R,4Rdicarboxylate (2R,4R-APDC) enhanced the release of nerve growth factor
The metabotropic glutamate receptors (mGluRs) that are expressed and not expressed on astrocytes in the brain have not been defined. While immunohistochemistry and in situ mRNA hybridization have been used on a limited basis to address this question, they do not readily enable the proportion of astr